The Valley Desk

NCT00234507 · Interventional trial

Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm

Overall registry status Completed

Phase 2

Conditions Blepharospasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov